Michael Chuong, MD

Occupational exposure during Lutetium-177 (Lu-177) radiopharmaceutical therapy depends on administration technique, shielding configuration, and staff proximity—temporal and spatial. This study quantified extremity and whole-body exposure contributions for va...

Efficacy, feasibility, and safety of extracranial, single-fraction MR-guided adaptive radiotherapy (SMART-1fx) was reported in the SMART ONE trial (NCT04939246). This work evaluates SMART plan quality relative to RTOG-0813 standards for an expanded cohort.